09.26.10
Tornier reported a milestone for its Salto Talaris total ankle prostheses. According to the company, U.S. surgeons now have implanted more than 3,000 of the devices, which have been designed as an alternative to ankle fusion for patients with intractable ankle pain. The original device, a three-part, mobile-bearing implant, has been in use in Europe since 1997.
The first Salto Talaris total ankle prosthesis procedure was conducted in the United States nearly four years ago. The Salto Talaris was designed to simulate the anatomy and motion of the normal ankle, while also facilitating the surgical procedure and minimizing bone loss, company officials noted. The implant is a precision-bearing design that is implanted using instrumentation designed to maximize the anatomic placement of device components.
Brian Donley, M.D., director of the Center of Foot and Ankle Surgery at the Cleveland Clinic, commented: “I am honored to have had the opportunity to implant the first Salto Talaris total ankle prosthesis in the United States in December of 2006. My positive experience with the Salto Talaris, as well as that of surgeons I have trained, suggest the long-term results with this device will emulate the excellent results of the Salto mobile-bearing system in Europe.”
According to Doug Kohrs, president and CEO of Tornier, the choices for patients with severe ankle pain in the United States has been limited by the lack of availability of durable ankle arthroplasty systems.
With U.S. headquarters in Edina, Minn., Tornier serves the orthopedic extremities market with devices for conditions of the shoulder, elbow, wrist, hand, ankle and foot.
The first Salto Talaris total ankle prosthesis procedure was conducted in the United States nearly four years ago. The Salto Talaris was designed to simulate the anatomy and motion of the normal ankle, while also facilitating the surgical procedure and minimizing bone loss, company officials noted. The implant is a precision-bearing design that is implanted using instrumentation designed to maximize the anatomic placement of device components.
Brian Donley, M.D., director of the Center of Foot and Ankle Surgery at the Cleveland Clinic, commented: “I am honored to have had the opportunity to implant the first Salto Talaris total ankle prosthesis in the United States in December of 2006. My positive experience with the Salto Talaris, as well as that of surgeons I have trained, suggest the long-term results with this device will emulate the excellent results of the Salto mobile-bearing system in Europe.”
According to Doug Kohrs, president and CEO of Tornier, the choices for patients with severe ankle pain in the United States has been limited by the lack of availability of durable ankle arthroplasty systems.
With U.S. headquarters in Edina, Minn., Tornier serves the orthopedic extremities market with devices for conditions of the shoulder, elbow, wrist, hand, ankle and foot.